Search

Copyright of Baghdad Science Journal is the property of Republic of Iraq Ministry of Higher Education & Scientific Research (MOHESR) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The chemical composition of the essential oil of Lindera subumbelliflora (Lauraceae) was investigated for the first time. The essential oil was obtained by hydrodistillation and fully characterised by gas chromatography (GC) and gas chromatography-mass spectrometry (GC-MS). The antifungal activity of L. subumbelliflora essential oil was tested against Candida albicans and Streptococcus mutans using the broth microdilution assay, whereas the microbial biofilms were determined using a semi-quantitative static biofilm. A total of 28 components (99.6%) were successfully identified, which were characterised by β-eudesmol (14.6%), cis-α-bergamotene (11.0%), α-copaene (8.5%), dodecen-1-ol (8.5%), and (E)-nerolidol (8.3%). The essential oil exhibited activity against Candida albicans and Streptococcus mutans with MIC values of 250 and 500 µg/mL, respectively. The essential oil increased the biofilm of Candida albicans by 38.25%, however, decreased the biofilm of Streptococcus mutans by 47.89% when treated with 500 µg/mL. Thus, the essential oil has a promising application in dentistry via inhibition of the growth of Candida albicans and Streptococcus mutans. However, the antibiofilm activity of the essential oil is only applicable for cariogenic Streptococcus mutans. [ABSTRACT FROM AUTHOR]

This study uses the aerial parts of Panicum maximum total extract (PMTE) to synthesize silver nanoparticles (AgNPs) in an environmentally friendly manner. TEM, SEM, FTIR, X-ray powder diffraction (XRD), Zeta potential, UV, and FTIR were used to characterize the green silver nanoparticles (PM-AgNPs). PM-AgNPs were evaluated as anticancer agents compared to (PMTE) against breast (MCF-7), lung (A549), and ovary adenocarcinoma (SKOV3) human tumour cells. The antibacterial activity of AgNPs was assessed against Staphylococcus aureus isolates. The PM-AgNPs had an absorbance of 418 nm, particle size of 15.18 nm, and zeta potential of −22.4 mV, ensuring the nanosilver's stability. XRD evaluated the crystallography nature of the formed PM-AgNPs. The cytotoxic properties of PM-AgNPs on MCF-7 and SKOV 3 were the strongest, with IC50s of 0.13 ± 0.015 and 3.5 ± 0.5 g/ml, respectively, as compared to A549 (13 ± 3.2 µg/mL). The increase in the apoptotic cells was 97.79 ± 1.61 and 96.6 ± 1.91% for MCF-7 and SKOV3 cell lines, respectively. PM-AgNPs were found to affect the membrane integrity and membrane permeability of 50 and 43.75% of the tested isolates, respectively. Also, PM-AgNPs have recorded a reduction in the biofilm formation of S. aurues. These results suggest using PM-AgNPs to treat breast and ovarian cancers. [ABSTRACT FROM AUTHOR]

Biofilm and bone tissue defect induced by the bacterial infection severely impede chronic osteomyelitis treatment. It is critical to break though the densely and obstinate biofilm so that the target drugs can deliver to the infected bone more effectively. Herein, an acoustically responsive multifunctional hydrogel microsphere-bomb (EMgel) was designed and prepared by microfluidic technology, which could be injected to the focus of bone infection, and blasted into the nidus deeply to destroy the bacterial biofilm matrix barrier under penetrating ultrasound, so the encapsulated natural polyphenolic EGCG and bioactive MoS 2 released to repair the damaged bone. The results proved the hydrogel microsphere-bomb exhibited controlling drug release, favorable antibacterial (as high as 99 %), high biofilm resistance, fascinating antioxidation, good cytocompatibility, and osteogenic differentiation. The acoustically responsive microsphere-bomb further proved their fantastic ability to eradicate biofilm and promote bone regeneration in the Methicillin-resistant Staphylococcus aureus (MRSA) infected chronic osteomyelitis model due to the synergy effects of EGCG and bioactive MoS 2. Especially, immunohistochemical staining showed lower inflammatory reaction and higher expression of OCN in EMgel group treated with ultrasound wave. This study presents a new design of hydrogel microsphere-based intelligence drug delivery for osteomyelitis treatment, which exhibit great promising potential for dealing with chronic orthopedic infections, drug delivery system and tissue engineering. [Display omitted] • An injectable acoustically responsive hydrogel microsphere-bomb were developed. • Explosion of microsphere-bomb under ultrasound maintains a balanced ROS level. • Synergistic and complementary effects on biofilm eradication and bone repair. [ABSTRACT FROM AUTHOR]

Objectives: This research first investigated the effect of mesoporous silica nanoparticles (nMS) carrying chlorhexidine and silver (nMS-nAg-Chx) on periodontitis-related biofilms. This study aimed to investigate (1) the antibacterial activity on Porphyromonas gingivalis (P. gingivalis) biofilm; (2) the suppressing effect on virulence of P. gingivalis biofilm; (3) the regulating effect on periodontitis-related multispecies biofilm. Methods: Silver nanoparticles (nAg) and chlorhexidine (Chx) were co-loaded into nMS to form nMS-nAg-Chx. Inhibitory zone test and minimum inhibitory concentration (MIC) against P. gingivalis were tested. Growth curves, crystal violet (CV) staining, live/dead staining and scanning electron microscopy (SEM) observation were performed. Biofilm virulence was assessed. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and Quantitative Real Time-PCR (qPCR) were performed to validate the activity and composition changes of multispecies biofilm (P. gingivalis, Streptococcus gordonii and Streptococcus sanguinis). Results: nMS-nAg-Chx inhibited P. gingivalis biofilm dose-dependently (p<0.05), with MIC of 18.75 µg/mL. There were fewer live bacteria, less biomass and less virulence in nMS-nAg-Chx groups (p<0.05). nMS-nAg-Chx inhibited and modified periodontitis-related biofilms. The proportion of pathogenic bacteria decreased from 16.08 to 1.07% and that of helpful bacteria increased from 82.65 to 94.31% in 25 μg/mL nMS-nAg-Chx group for 72 h. Conclusions: nMS-nAg-Chx inhibited P. gingivalis growth, decreased biofilm virulence and modulated periodontitis-related multispecies biofilms toward healthy tendency. pH-sensitive nMS-nAg-Chx inhibit the pathogens and regulate oral microecology, showing great potential in periodontitis adjunctive therapy. [ABSTRACT FROM AUTHOR]

Chronic wound is a major clinical challenge that complicates wound healing, mainly associated with bacterial biofilms. Bacterial burden damages tissue and persists inflammation, failing to granulate, leading to morbidity and mortality. Various therapeutic strategies and approaches have been developed for chronic wound healing in clinical practice. As treating biofilm infection is crucial in chronic wounds, a potent antibiofilm agent, essential oils have been explored extensively for their therapeutic properties and as a replacement for antibiotic therapy. Currently, several studies on essential oils and their active compounds in therapeutics, such as adjunctive therapies, nanotechnology-based treatment and their drug delivery systems, help heal chronic wounds. The antimicrobial, anti-inflammatory and antioxidant properties of essential oils make them distinct and are renowned as natural remedies to improve the healing of infected chronic wounds. Consequently, it accelerates wound closure by reducing inflammation, increasing angiogenesis and tissue regeneration. This review focuses on different essential oils and their active compounds that are exploited for the treatment of biofilm infection, chronic inflammation and wound healing. Thus, an effective novel treatment can be developed to improve the current treatment strategy to overcome multidrug resistance bacteria or antibiotic resistance in various chronic wound infections that support wound healing. [ABSTRACT FROM AUTHOR]

A large number of recalcitrant bacterial pathogens cannot be easily treated by antibiotics due to the existence of biofilm. Hence, an alternative strategy needs to be adopted to remove the biofilm without the development of antibiotic resistance. Bacteriocins, ribosome-mediated bacterial proteinaceous toxins, are found to have the potential to inhibit the growth of bacteria. In the present study, leucocin, extracted and purified from previously isolated bacteriocin-producing strain Leuconostoc lactis, showed a marked reduction (around 80%) in the growth of planktonic cells of Gram-negative Escherichia coli ATCC 25,922 compared to Nisin, a reference bacteriocin, and tetracycline, a conventional antibiotic. The considerable inhibition of the biofilm forming sessile cells with no significant cell revival even after removal of the treatment was also perceived. The scanning electron micrographs showed the considerable antibiofilm activities of the bacteriocin against the test organism. The bacteriocin treatment-mediated changes in the functional groups of the biofilm matrices are clearly visible from FTIR analysis. The confocal microscopic images showed the affinity of the bacteriocin towards the genetic material of the test organism and the reduction of the biofilm forming cells, which confirms the higher competence of the present leucocin as an antibiofilm agent in order to replace the conventional antibiotic. [ABSTRACT FROM AUTHOR]

The rapid spread of the drug-resistance among microbes has made the treatment of infections a problematic task. Microbial biofilms are complex aggregations of microbial cells encapsulated in a polymeric matrix that further worsens the treatment of microbial infections. In this study, ZnONPs were synthesized via green route using the aqueous tuber extract of Drynaria quercifolia. Biophysical property of ZnONPs was characterized by UV-vis spectroscopy, XRD, FTIR, SEM with EDS, and HR-TEM analyses and was found to have a size of 10 nm. Synthesized ZnNOPs demonstrated good antimicrobial activity against bacterial (B. cereus, S. typhi, and E. coli) and fungal (A. flavus and C. albicans) strains. Subsequently, the ZnONPs also exhibited excellent antioxidant property DPPH (78.52%), ABTS assay (70.18%), and hydroxyl scavenging assay (77.34%) at 100 μg/ml concentration. The biofilm inhibitory activity against E. coli, B. cereus, and S. typhi was recorded. Additionally, we also evaluated the larvicidal activity of ZnONPs against Cx. quinquefasciatus and recorded LC50 value of 130.725 μg/ml. Histopathology studies revealed that the region of hind and mid intestine, epithelial cells, and cortex were affected severely upon the treatment with ZnONPs. Photocatalytic activity was tested on crystal violet for dye degradation. Nearly complete degradation of the tested dye occurred within 72 min. The study suggests that green-synthesized ZnONPs could be a preferred alternative for various biomedical applications and contribute to the eventual elimination of environmental pollutants in the near future. [ABSTRACT FROM AUTHOR]

Cyanobacteria, a group of oxygenic photosynthetic prokaryotes, are emerging as promising biofactories for the eco-benign and sustainable production of metal oxide nanoparticles. These blue-green algae are particularly grabbing attention for nanoparticle biosynthesis owing to their potential to produce unique metabolites that can successfully reduce and cap nanoparticles. The current research explores the use of an organic biomass extract of indigenous Nostoc sp. SI-SN for the biofabrication of zinc oxide nanoparticles (ZnO-NPs). Their successful synthesis was confirmed with UV–Vis, FTIR, XRD, and SEM analyses with a 370-nm absorption band and a crystal size of 18.47 nm, showing a quasi-spherical to hexagonal morphology due to capping and stabilization by polyphenolic compounds. The ZnO-NPs showed antibacterial potential against clinical pathogens, with minimum inhibitory concentrations (MICs) ranging from 10.06 to 48.5 µg/ml. They also demonstrated anti-exopolysaccharide, anti-biofilm, and anti-quorum sensing activity up to 86, 100, and 88%, respectively, at a sub-MIC value of 32 µg/ml after 24 h. They also possessed potent antioxidant potential, with an EC50 value of 39.51 µg/ml. No significant genotoxic effect was recorded against plasmid DNA at or below the concentration of 25 µg/ml after 4 h. Furthermore, seed germination, seedling parameters, and chlorophyll content were significantly enhanced with ZnO-NPs at concentrations of 10 and 15 µg/ml in corn and wheat, respectively. Thus, the organic biomass extract of Nostoc sp. SI-SN could be used as a safe, sustainable, and green alternative for the production of multifunctional ZnO-NPs, not only in the biomedical field but also as nano-fertilizers in agricultural applications for sustainable development. [ABSTRACT FROM AUTHOR]

The World Health Organization has identified Acinetobacter baumannii as the most threatening multidrug-resistant pathogen, necessitating the development of new antimicrobial agents. In this study, the antibacterial, anti-adhesion, and antibiofilm activities of Eryngium ilicifolium against carbapenem resistant A. baumannii were investigated, alongside its impact on surface physicochemical properties. Among the extracts tested, only the Soxhlet diethyl ether extract exhibited effectiveness, with inhibition diameters ranging from 20.7 to 23.3 mm, and minimum inhibitory and bactericidal concentrations between 0.156 and 0.625 mg/ml. The anti-adhesion assay of this extract yielded promising results, showing inhibition percentages between 0.92% and 29.24%. However, the extract was active against only one strain of biofilm. Moreover, treatment with E. ilicifolium did not alter the hydrophobic nature of the surface. Nevertheless, the E. ilicifolium extract demonstrated significant efficacy against A. baumannii in planktonic form and could potentially serve as an effective preventive strategy against biofilm formation. [ABSTRACT FROM AUTHOR]

Introduction: Dental caries, caused by oral microbial pathogens, are a global health concern, further exacerbated by the presence of methicillin-resistant Staphylococcus aureus (MRSA). Bioactive proteins and peptides (BAPs) exhibit potent antimicrobial properties, targeting multiple cellular mechanisms within pathogens, reducing the likelihood of resistance development. Given the antimicrobial potential of BAPs, this study aimed to compare the efficacy of BAPs extracted from cultivated (Pleurotus ostreatus , PoC) and wild (Pleurotus ostreatus , PoW) mushrooms against pathogens responsible for dental caries. Methods: BAPs were extracted from both PoC and PoW using a TCA-acetone method. Antimicrobial activities were tested against seven bacteria and one fungus using agar well diffusion and MIC determination. Antibiofilm activity was assessed via modified CV assay, while DPPH and erythrocyte lysis tests evaluated free radical scavenging. Results: PoC showed superior antimicrobial efficacy, with lower MIC and MBC values, and disrupted biofilm integrity at increasing concentrations. PoW exhibited better antioxidant activity with higher DPPH scavenging, though its antimicrobial efficacy was slightly lower than PoC. Discussion: Both PoC and PoW BAPs inhibited dental pathogens, with PoC showing stronger inhibition against MRSA and nystatin-resistant Candida albicans. This suggests BAPs may target additional cellular mechanisms beyond membranes, PBPs, and ergosterols. Despite PoW's stronger antioxidant properties, both BAPs had comparable antibiofilm activity. These findings suggest complementary actions of BAPs from PoC and PoW both, in treating dental caries, offering broad-spectrum antimicrobial and antioxidant benefits. [ABSTRACT FROM AUTHOR]

Nanomaterials with enzyme-like properties are known as 'nanozymes'. Nanozymes are preferred over natural enzymes due to their nanoscale characteristics and ease of tailoring of their physicochemical properties such as size, structure, composition, surface chemistry, crystal planes, oxygen vacancy, and surface valence state. Interestingly, nanozymes can be precisely controlled to improve their catalytic ability, stability, and specificity which is unattainable by natural enzymes. Therefore, tailor-made nanozymes are being favored over natural enzymes for a range of potential applications and better prospects. In this context, metal oxide nanoparticles with nanozyme-mimicking characteristics are exclusively being used in biomedical sectors and opening new avenues for future nanomedicine. Realising the importance of this emerging area, here, we discuss the mechanistic actions of metal oxide nanozymes along with their key characteristics which affect their enzymatic actions. Further, in this critical review, the recent progress towards the development of point-of-care (POC) diagnostic devices, cancer therapy, drug delivery, advanced antimicrobials/antibiofilm, dental caries, neurodegenerative diseases, and wound healing potential of metal oxide nanozymes is deliberated. The advantages of employing metal oxide nanozymes, their potential limitations in terms of nanotoxicity, and possible prospects for biomedical applications are also discussed with future recommendations. [ABSTRACT FROM AUTHOR]

Objectives: Food products are often contaminated by pathogens and spoilage bacteria. Most of them can form biofilms, a community of cells embedded in protective extracellular matrix layers resistant to harsh conditions, including antibiotics. Therefore, alternative antibiofilm agents are required to overcome biofilm formation. This study aims to determine and quantify the antibiofilm activity of supernatants from plant-associated bacteria against biofilms of foodborne pathogen and food spoilage bacterium, namely Bacillus cereus and Bacillus subtilis. Results: Plant-associated bacteria (PAB) have shown promising antibiofilm activities against biofilm-forming pathogens in previous studies. Thirteen PAB isolated from Ternate, Indonesia were used in this study. Supernatants of PAB were subjected to antimicrobial activity and quorum quenching detection, both using the well diffusion method. Four supernatants inhibited the growth of B. subtilis, but none affected the growth of B. cereus. Eight supernatants were able to disrupt the quorum sensing system of an indicator bacterium, wild-type Chromobacterium violaceum. Biofilm inhibition and destruction were quantified using 96-well microplates. The highest biofilm inhibition and destruction activities of PAB supernatants against each of B. cereus and B. subtilis biofilms were > 76%, and were later confirmed by light microscope and scanning electron microscope. Brine shrimp lethality assay (BSLA) was conducted and revealed that the selected PAB supernatants were non-toxic. The 16S rRNA gene of PAB were sequenced and they showed similarities to Bacillus, Priestia, and Chryseobacterium. Compounds in the supernatants were determined by GC–MS which revealed contents of fatty acids, ethyl esters, and diketopiperazines. Therefore, PAB supernatants have potential as antibiofilm agents against biofilm formed by Bacillus cereus and Bacillus subtilis. [ABSTRACT FROM AUTHOR]

Despite advancements in therapeutic agents for diabetic chronic wounds, challenges such as suboptimal bioavailability, intricate disease milieus, and inadequate delivery efficacy have impeded treatment outcomes. Here, ultrasound‐responsive hydrogel incorporated with heparin‐binding domain (HBD) peptide nanoparticles is developed to promote diabetic wound healing. HBD peptide, derived from von Willebrand Factor with angiogenic activity, are first engineered to self‐assemble into nanoparticles with enhanced biostability and bioavailability. Ultrasound responsive cargo release and hydrogel collapses are first verified through breakage of crosslinking. In addition, desired antioxidant and antibacterial activity of such hydrogel is observed. Moreover, the degradation of hydrogel under ultrasound stimulation into smaller fragments facilitated the deeper wound penetration of ≈400 µm depth. Complete wound closure is observed from diabetic mice with chronic wounds after being treated with the proposed hydrogel. In detail, in vivo studies revealed that hydrogels loaded with HBD peptide nanoparticles increased the levels of angiogenesis‐related growth factors (VEGF‐A, CD31, and α‐SMA) to effectively accelerate wound repair. Overall, this study demonstrates that ultrasound‐responsive HBD peptide hydrogel provides a synergistic therapeutic strategy for external biofilm elimination and internal effective delivery for diabetic wounds with biofilm infection. [ABSTRACT FROM AUTHOR]

This work characterizes microemulsions of Medicago marina essential oil and evaluates their antimicrobial, antibiofilm, and anticoagulant effects. Medicago marina L. aerial parts essential oil was hydro-distilled and analyzed by gas chromatography-FID and gas chromatography/mass spectrometry (GC/MS) for the first time from the Tunisian chemotype. The microemulsion was prepared using an oil/water formulation with a biopolymer (Arabic gum) and surfactant (Tween 20). Antibacterial and antifungal activities were evaluated using the microbroth dilution method, while anticoagulant activity was tested in vitro using prothrombin time (PT) and aPTT tests. Eventually, the binding affinities and molecule’s interactions of the main chemicals with the operational locations of C (30) carotenoid dehydrosqualene synthase and cytidine deaminase were explored. The essential oil contained 71 compounds of which 87.6% were identified. Major compounds were β-ionone (17.67%), 1-methyleugenol (10.75%), eugenol (8.86%), β-damascenone (4.33%), and α-humulene (4.32%). A microemulsion with a diameter of 1.63 μ m, a polydispersity index of 0.17, a zeta potential of –40.8 mV and a pH of 6 was obtained and it showed the highest antibacterial potential against a multitude of microbes, with low MICs varying between 0.406 mg/mL and 3.25 mg/mL. Significant antibiofilm activity was observed with over 80% inhibition at 4 × MIC concentration. It showed better anticoagulant activity than heparin, with PT and aPTT values of 19.5 s and 57 s, respectively, at 10 mg/mL. Molecular docking showed that “(E)-β-ionone” had the highest binding scores. Notable pharmacokinetic and drug-like qualities were found in the obtained molecules after establishing ADME profiling. As a result, Medicago marina L. Essential oil microemulsion can be used in food processing as a preservative. [ABSTRACT FROM AUTHOR]

The goal of the current work was to investigate the antibacterial, antibiofilm, anticancer, and antioxidant opportunities of silver and gold nanoparticles (AgNPs and AuNPs) synthesized utilizing a new fungus strain called Fusarium pseudonygamai TB-13c. With the aid of UV, HR-TEM, FTIR, SEM, and XRD, the NPs' creation was examined. For AgNPs and AuNPs, the mycosynthesized NPs' highest peak plasmon band was seen at around 420 and 540 nm, respectively. AgNPs ranged in size from 5 to 20 nm, whereas AuNPs ranged in size from 8 to 60 nm. AgNPs and AuNPs were spherical in form. For AgNPs, the angles were 38.42°, 44.56°, 64.66°, and 77.75°; for AuNPs, the angles were 38.56°, 44.74°, 64.87°, and 77.85°. The antibacterial efficiency of AgNPs and AuNPs was evaluated against Klebsiella pneumoniae, Pseudomonas aeruginosa, methicillin-sensitive Staphylococcus aureus (MSSA), and methicillin-resistant Staphylococcus aureus (MRSA). In particular, AgNPs outperformed AuNPs in their ability to combat pathogenic microorganisms. Furthermore, antibiofilm study that shown AuNPs had activity more than AgNPs. Interestingly, applying the DPPH procedure these noble metallic NPs had antioxidant activity, which the IC50 for AgNPs was 38.2 μg/ mL and 180 μg/ mL for AuNPs. The modification in the cells was evident in the cytotoxicity evaluation findings as change of their usual shape, partially or completely loss of monolayer, granulation, and shrinkage, or cell rounding with IC50 for normal vero cell were 695.34 μg/mL and 631.66 μg/mL for AgNPs and AuNPs, respectively, whilst IC50 for cancer cell (Mcf7) was 204.07 μg/mL for AgNPs and 206.95 μg/mL for AuNPs. The combined results show that there is a clear and flexible biological use for less toxic chemotherapeutic agents. [ABSTRACT FROM AUTHOR]

Bacterial biofilms often lead to persistent infections because they provide a protective barrier and reproductive microenvironment for bacteria. Biofilms reduce the therapeutic effects of antibiotics and can easily lead to the emergence of multidrug‐resistant bacteria. Therefore, development of new materials for antibiofilm with synergistic effects is crucial. In this study, positively charged near‐infrared‐responsive nanoparticles (TDPPB) are synthesized to control the release and delivery of nitric oxide (NO) gas. A combination of NO and photothermal therapy (PTT) is used to enhance the antibiofilm performance of TDPPB. The positive charge of TDPPB induces the nanoparticles to adhere to the surface of the bacteria. Through 808 nm laser irradiation, the local high temperature triggers the efficient release of NO from the NO donor (BNN 6) in TDPPB. TDPPB integrates the release of NO, and PTT presents good antibiofilm activity against MRSA and Escherichia coli (E. coli) biofilms. TDPPB demonstrates excellent biosafety both in vivo and in vitro, shows good antibiofilm properties in biofilm‐infected mice, and promotes the healing of surface‐infected sites in vivo. Because of these advantages, TDPPB can be used as a potential therapeutic agent against biofilm infections in the biomedical field. [ABSTRACT FROM AUTHOR]

Nanostructured materials are advantageous within numerous fields of medicine owing to their intriguing qualities, which include their size, reactive surface, bioactivity, potential for modification, and optical characteristics. Cassia javanica flower extract was used as a chelating agent in an environmentally friendly process to create SeNPs FTIR, XRD, and TEM, SAED were utilized to analyze and characterize the synthesized. The findings showed that the MIC of Se NPs against B. subtilis and S. aureus was 500 µg/ml. Conversely, the MIC for P. aeruginosa, E. coli, and C. albicans were 125, 250, and 62.5 µg/ml, respectively. Hence, SeNPs considerably reduced the activity; the inhibition peaked at 77.6% at 250 µg/ml to reach 49.04% at 7.8 µg/ml. Which showed the greatest suppression of MRSA biofilm formation without affecting bacterial growth. SeNPs showed an intriguing antioxidant capacity, achieving an IC50 of 53.34 µg/ml. This study looked how soaking seeds before sowing them with Se NPs at 50, 100, and 200 ppm affected the plants' development in different parameters, as well as their yield of Vicia faba L. The growth conditions were effectively increased by soaking application of various quantities of Se NPs. The highest values of dry weight/pod (g), number of seeds/plant, weight of 100 seeds (g), and number of pods/plant were caused by high concentrations of Se NPs, by 28.43, 89.60, 18.20, and 94.11%, respectively. [ABSTRACT FROM AUTHOR]

The wounds, arises from accidents, burns, surgeries, diabetes, and trauma, can significantly impact well‐being and present persistent clinical challenges. Ideal wound dressings should be flexible, stable, antibacterial, antioxidant and anti‐inflammatory in nature, facilitating a scarless rapid wound healing. Initiatives were taken to create antibacterial cotton fabrics by incorporating agents like antibiotics and metallic nanoparticles. However, due to a lack of multifunctionality, these materials were not highly effective in causing scarless and rapid wound healing. In this article, nickel thiocyanate nanoparticle (NiSCN‐NPs) impregnated cotton gauze wound dressing (NiSCN‐CG) was developed. These nanoparticles were non‐toxic to normal human cell lines till 1 mg/mL dose and did not cause skin irritation in the rat model. Further, NiSCN‐NPs exhibited antimicrobial, antibiofilm and antioxidant activities confirmed using different in vitro experiments. In vivo wound healing studies in rat models using NiSCN‐CG demonstrated rapid scarless wound healing. The nickel thiocyanate impregnated cotton gauze presents a novel approach in scarless wound healing, and as an antimicrobial agent, offering a promising solution for diverse wounds and infections in the future. [ABSTRACT FROM AUTHOR]

Background: Fixed orthodontic appliances act as a niche for microbial growth and colonization. Coating orthodontic wires with antimicrobial silver nanoparticles (AgNPs) and nanocomposite was adopted in this study to augment the biological activity of these wires by increasing their antibacterial and antibiofilm properties and inhibiting bacterial infections that cause white spot lesions and lead to periodontal disease. Methods: Three concentrations of biologically synthesized AgNPs were used for coating NiTi wires. The shape, size, and charge of the AgNPs were determined. Six groups of 0.016 × 0.022-inch NiTi orthodontic wires, each with six wires, were used; and coated with AgNPs and nanocomposites. The antimicrobial and antibiofilm activities of these coated wires were tested against normal flora and multidrug-resistant bacteria (Gram-positive and Gram-negative bacterial isolates). The surface topography, roughness, elemental percentile, and ion release were characterized. Results: AgNPs and nanocomposite coated NiTi wires showed significant antimicrobial and antibiofilm activities. The chitosan-silver nanocomposite (CS-Ag) coated wires had the greatest bacterial growth inhibition against both Gram-positive and Gram-negative bacteria. The surface roughness of the coated wires was significantly reduced, impacting the surface topography and with recorded low Ni and Ag ion release rates. Conclusions: NiTi orthodontic wires coated with AgNPs, and nanocomposites have shown increased antimicrobial and antibiofilm activities, with decreased surface roughness, friction resistance and limited- metal ion release. [ABSTRACT FROM AUTHOR]

Aims Staphylococcus aureus , a high-priority pathogen proclaimed to cause infections ranging from mild to life-threatening, presents significant challenges in treatment. New therapies can be developed quicker using open drug discovery platforms offering a distinct approach to expedite the development of innovative antibacterial and anti-biofilm therapeutics. This study set out to address these issues by finding new uses for current medications to find compounds that are effective against S. aureus. Methods and results In this study, we screened the global priority health box, launched by Medicines for Malaria Ventures containing 240 compounds, for their effectiveness against S. aureus. MMV1795508, MMV1542799, MMV027331, MMV1593278, and MMV1804559 showed potential antibacterial activity at 10 µM concentration. These compounds underwent further evaluation for their ability to clear intracellular bacteria, disrupt biofilm formation, and eradicate existing biofilms. MMV1804559 demonstrated strong efficacy across all tested parameters, achieving 94% inhibition of intracellular bacteria, 79.19% disruption of biofilm cells, and 66.18% inhibition of biofilm formation. Scanning electron microscopy revealed notable membrane perforations and blebbing in MMV1804559-treated cells, indicating its impact on bacterial membranes. Gene expression analysis of cells treated with MMV1804559 showed downregulation of clfA and clfB genes, critical for biofilm formation. Additionally, docking studies confirmed the binding affinity of MMV1804559 with clfA , supported by favorable docking scores, MM/GBSA binding energy, and increased hydrogen bond interactions in the binding pocket, suggesting clfA as a target for MMV1804559. Conclusions MMV1804559 could serve as a potential therapy for S. aureus by targeting biofilm development and cell adhesion processes. [ABSTRACT FROM AUTHOR]

This work examined the antibacterial and antibiofilm properties of alginate/collagen nanoparticles containing limonene. The multi-drug resistant (MDR) strains were screened, and the morphological features of the produced nanoparticles were determined utilizing SEM, DLS, and FTIR. Additionally, the encapsulation effectiveness, stability, and drug release were assessed. The levels of OmpA and Bap biofilm genes were assessed using qRT-PCR. At the same time, the antibacterial and cytotoxic activities of the nanoparticles were evaluated using well diffusion and MTT techniques, respectively. LAC nanoparticles measuring 300 ± 9.6 nm in size, 83.64 ± 0.19% encapsulation efficiency, and 60-day stability at 4 °C were synthesized. The biological investigation demonstrated that LAC nanoparticles had potent antibacterial capabilities. This was shown by their ability to significantly decrease the transcription of OmpA and Bap biofilm genes at a statistically significant level of p ≤ 0.05. The nanoparticles exhibited reduced antibiotic resistance compared to free limonene and alginate/collagen. Compared to limonene, LAC nanoparticles exhibited negligible cytotoxicity against HEK-293 at doses ranging from 1.56 to 100 µg/mL (p ≤ 0.01). The findings underscore the potential of LAC nanoparticles as a breakthrough in the fight against highly resistant pathogens. The potent antibacterial effects of LAC nanoparticles versus Acinetobacter baumannii (A. baumannii) MDR strains, considered highly resistant pathogens of significant concern, could inspire new strategies in antibacterial research. [ABSTRACT FROM AUTHOR]

The traditional medicinal value of Curcuma longa (turmeric) and its potential relevance in modern healthcare suggests that traditional remedies and natural products can provide valuable solutions to contemporary challenges, such as combating biofilms and antibiotic-resistant pathogens, potentially offering new strategies for addressing health and safety issues in the fields of food and medicine. This study assessed the antibiofilm and antibacterial characterization of Curcuma longa rhizome extract against antibiotic-resistant foodborne pathogens. Gas Chromatography-Mass Spectrometry (GC-MS) and Fourier-transform infrared (FTIR) analysis were determined to check for the compounds, functional groups, and constituents of the plant extract. In-vitro antibiofilm and antibacterial bioassay of the extract were determined using standard bacteriological procedures. Potential mechanisms of the plant extract were also studied using standard biological methods. The important chemical constituents from the GC-MS extract of C. longa are arturmerone, cinnamyl angelate, tumerone, γ-atlantone, atlantone, α-atlantone, γ-atlantone and curlone. The FTIR analysis of the extract comprises alkyl halides, bromoalkanes, alkanes, ethylene molecules, arenes, amines, alcohols, sulfones, carboxylic acids and their derivatives, aromatic compounds, and phenols. The MIC of C. longa crude extract ranges from ethanol extract (0.03125 − 0.5 mg/mL) and acetone extract (0.0625 − 0.5 mg/mL). The MBC range is as follows: ethanol extract (0.125 − 1 mg/mL), acetone extract (0.125 − 1 mg/mL). The time-kill kinetics showed significant cell reduction with time. The bacterial isolates' nucleic acids and protein leakage were consistent with increased extract concentration and time. There was a reduction in the biofilm cell on the shrimp surface and EPS with increased concentration and time. C. longa exerted significant anti-biofilm activity by removing existing biofilms, disrupting cell connections, and decreasing cells in biofilms. These findings can aid food protection from microbial contamination and prevent biofilms-related infections. [ABSTRACT FROM AUTHOR]

Nanotechnology is used in several biomedical applications, including antimicrobial and antibiofilm applications using nanomaterials. Bacterial biofilm varies according to the strain; the matrix is very strong and resistant. In this sense, phytosynthesis is an important method for combating bacterial biofilms through the use of metallic nanoparticles (silver, gold, or copper) with increased marketing and technical-scientific potential. In this review, we seek to gather the leading publications on the use of phytosynthesized metallic nanoparticles against bacterial biofilms. Furthermore, this study aims to understand the main characteristics and parameters of these nanomaterials, their antibiofilm efficiency, and the presence or absence of cytotoxicity in these developed technologies. [ABSTRACT FROM AUTHOR]

Antibiotic resistance has increased in recent years, especially for pathogens like Klebsiella pneumoniae. Discovering and developing new drugs is challenging due to the high resistance of pathogens. Metal nanoparticles have been widely used in recent years to overcome and treat infections. Gallic acid‐coated iron oxide nanoparticles (IONPs‐GA) were synthesized in a simple and cost‐effective method. The morphology characteristics of synthesized IONPs‐GA were analyzed using Fourier transform infrared spectroscopy (FTIR), x‐ray diffraction analysis (XRD), and scanning electron microscope (SEM) analysis. IONPs were mostly spherical in shape with sizes ranging between 32 and 61 nm. All analyses used in this study confirmed the successful coating of gallic acid to iron oxide. Biological activities were studied phenotypically and on the molecular level, including antibacterial, antibiofilm, and mRNA levels of capsule‐associated genes. The results showed high antimicrobial activity of the synthesized nanoparticles against different G+ve and G−ve bacteria. The highest activity was recorded against Staphylococcus aureus (43 mm) and K. pneumoniae (22 mm). The MIC of IONPs against K. pneumoniae was 3.12 mg/mL and SEM analysis showed adhering the IONPs‐GA to the cell surface of K. pneumoniae resulted in disrupting the cell membrane. Different concentrations of sub‐MIC inhibited K. pneumoniae biofilm formation with the highest inhibition percentage at ½ × MIC (66.86%). Also, the synthesized IONPs‐GA differently affected the regulation and mRNA level of capsule‐associated genes in K. pneumoniae. The results indicated that IONPs‐GA could be useful in biological applications such as in drug delivery and treatment wide range of pathogens. Research Highlights: Gallic acid was successfully coated into iron oxide nanoparticles synthesized in a simple way.IONPs‐GA was morphologically characterized using FTIR, XRD, and SEM.Evaluation the activity of IONPs‐GA as antibacterial, antibiofilm, and study the potential level of mRNA affected by IONPs‐GA [ABSTRACT FROM AUTHOR]

Eschar and slough in wounds serve as a reservoir for microorganisms and biofilms, damaged/devitalised cells, and inflammatory chemokines/cytokines, which work to initiate and prolong persistent inflammation and increase the risk of infection. Biofilm-related inflammation and infections are considered to be highly prevalent in acute wounds and chronic wounds. As slough is known to harbour biofilms, measuring the efficacy of antimicrobials in killing microbes both within and under slough is warranted. This highlights the need for more clinically relevant wound biofilm models to address this significant clinical need. Consequently, in this study, we developed an in vitro artificial wound slough (AWS) biofilm model produced by forming a biofilm below a layer of AWS, the latter of which was composed of the main protein components reported in wound eschar and slough, namely collagen, elastin, and fibrin. The model was employed to investigate the antibiofilm and antibacterial efficacy of a new patented smart next-generation antibiofilm technology composed of silver–zinc EDTA complexes and designed as a family of multifunctional metal complexes referred to as MMCs, in a liquid format, and to determine both the performance and penetration through AWS to control and manage biofilms. The results demonstrated the ability of the AWS–biofilm model to be employed for the evaluation of the efficacy of a new antibiofilm and antimicrobial next-generation smart technology. The results also demonstrated the potential for the proprietary EDTA multifunctional metal complexes to be used for the disruption of biofilms, such as those that form in chronic wounds. [ABSTRACT FROM AUTHOR]

The current study focused on the synthesis of doped silver nanoparticles (doped AgNPs) with yttrium (Y), gadolinium (Gd), and chromium (Cr) from pine needle leaf extract (PNLE). X-ray diffraction (XRD) was performed to assess the phase formation, detecting 61.83% from Ag and 38.17% for secondary phases of AgCl, AgO, Y, Cr-, and Gd phases. The size and shape of the NPs were determined by transmission electron microscopy (TEM), showing a spherical shape with an average particle size of 26.43 nm. X-ray photoelectron spectroscopy (XPS) detected the oxidation state of the presented elements. The scanning electron microscope (SEM) and the energy-dispersive X-ray analysis (EDX) determined the morphology and elemental composition of the NPs, respectively. Fourier transform infrared spectroscopy (FTIR) determined the different functional groups indicating the presence of Ag, Y, Gd, Cr, and other groups. Photoluminescence (PL) spectroscopy showed the optical properties of the NPs. A vibrating sample magnetometer (VSM) revealed the ferromagnetic behavior of the doped AgNPs. The antibacterial activity of the doped AgNPs was tested against six uro-pathogenic bacteria (Staphylococcus aureus, Staphylococcus haemolyticus, Enterococcus faecalis, Escherichia coli, Klebsiella pneumonia, and Pseudomonas aeruginosa) using the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) microdilution assays, agar well diffusion assay, time–kill test, and antibiofilm screening assays, revealing significant activity, with MICs ranging between 0.0625 and 0.5 mg/mL and antibiofilm activity between 40 and 85%. The antioxidant activity was determined by the 1,1, diphenyl 1-2 picrylhydrazyl (DPPH) radical scavenging assay with a potential of 61.3%. The docking studies showed that the doped AgNPs had the potential to predict the inhibition of crucial enzymes such as penicillin-binding proteins, LasR-binding proteins, carbapenemase, DNA gyrase, and dihydropteroate synthase. The results suggest that the doped AgNPs can be applied in different medical domains. [ABSTRACT FROM AUTHOR]

Chitosan-Silver Nanoparticles are effective at targeting various molecular and physiological activities of bacteria. The current study focused on the phytosynthesis of chitosan-silver nanoparticles (CS-AgNPs) from Acacia glauca leaf extract and assessed their impact on the expression of quorum sensing and hemolysin genes in Staphylococcus aureus. The appearance of a dark brown color and a surface plasmon resonance peak at 432 nm were the primary indicators of CS-AgNP formation. SEM and TEM images revealed that the nanoparticles had an almost spherical shape with an average particle size of 8 nm. A zeta potential of + 33 mV confirmed high colloidal stability, and the XRD pattern matched the silver crystal lattice structure, indicating a high degree of crystallinity. The synthesized nanoparticles exhibited a strong anti-Staphylococcus aureus effect with a minimum inhibitory concentration (MIC) of 4 µg/mL. Moreover, the CS-AgNPs exhibited significant antibiofilm activity. RT–PCR analysis revealed a significant reduction in the translation of quorum sensing and hemolysin genes upon exposure to a subinhibitory concentration of CS-AgNPs. Chitosan-silver nanoparticles have the potential to be effective antibacterial agents by targeting the molecular mechanisms of multidrug-resistant S. aureus. [ABSTRACT FROM AUTHOR]

This research aims to develop a novel approach, employing cold plasma technology for preparing nanoparticles of silver oxide by Anethum graveolens (dill) leaf extract as a natural reducing agent. This investigation evaluated the properties of antibacterial and antibiofilm-prepared nanoparticles. Initially, dill leaf extract was prepared to stabilize and reduce the size of silver oxide nanoparticles. Improved synthesis and optimal conditions for nanoparticle formation were achieved through the application of cold plasma technology. The results obtained showed that the prepared silver oxide nanoparticles have strong antibacterial properties and that they have antibacterial activity against a different group of bacteria that cause diseases such as Klebsiella pneumoniae (K. pneumoniae), Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). The results also showed the effectiveness of nanoparticles in preventing the formation of bacterial biofilms, as the highest rate of inhibition was for gram-positive bacteria S. aureus. This study demonstrated the effectiveness of plant extracts and cold plasma technology when combined in producing nanoparticles with improved properties, which may push toward the employment of these materials in developing innovative and sustainable solutions in various scientific and applied fields. [ABSTRACT FROM AUTHOR]

AbstractIn this context, we designed and synthesized a series of hydrazonal and their related indeno[1,2-b]pyridin-5-one derivatives to investigate their antibacterial and anti-biofilm properties. Several of the synthesized compounds exhibited significant efficacy against all microorganism species tested. Most of the compounds demonstrated favorable results when tested against Gram-positive bacteria. The derivatives 4a, 4f, 6c, and 6f exhibit the highest antimicrobial efficacy, as indicated by their minimum inhibitory concentration (MIC) values ranging from 4 to 512 μg/mL. We conducted additional investigations on 4a, 6c, and 6f for the purpose of examining their synergy using Checkerboard assay. Compound 6c demonstrated a synergistic impact against methicillin-sensitive Staphylococcus aureus (MSSA) and Pseudomonas aeruginosa, while exhibiting moderate synergistic activity against methicillin-resistant Staphylococcus aureus (MRSA). In addition, the simultaneous use of gentamycin with compounds 4a and 6f demonstrates a synergistic impact in fighting against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa, respectively. Three chosen compounds were evaluated for their antibiofilm efficacy. Application of 4a, 6c, and 6f effectively reduced the production of biofilms in MRSA, MSSA, and Pseudomonas aeruginosa, resulting in a significant decrease compared to the untreated samples. In addition, ADME and pharmacokinetic analyses were conducted for the three most potent derivatives, namely 4a, 6c, and 6f. Compounds 4a and 6c were subjected to docking in the LasR Quorum-Sensing Receptor, whereas compounds 6c and 6f were docked in the sortase enzyme. [ABSTRACT FROM AUTHOR]

The development of new antibacterial drugs is essential for staying ahead of evolving antibiotic resistant bacterial (ARB) threats, ensuring effective treatment options for bacterial infections, and protecting public health. Herein, we successfully designed and synthesized two novel gold(III)‐ NHC complexes, [Au(1)(bpy)Cl][PF6]2 (2) and [Au(1)(phen)Cl][PF6]2 (3) based on the proligand pyridyl[1,2‐a]{2‐pyridylimidazol}‐3‐ylidene hexafluorophosphate (1⋅HPF6) [bpy=2,2′‐bipyridine; phen=1,10‐phenanthroline]. The synthesized complexes were characterized spectroscopically; their geometries and structural arrangements were confirmed by single crystal XRD analysis. Complexes 2 and 3 showed photoluminescence properties at room temperature and the time‐resolved fluorescence decay confirmed the fluorescence lifetimes of 0.54 and 0.62 ns respectively; which were used to demonstrate their direct interaction with bacterial cells. Among the two complexes, complex 3 was found to be more potent against the bacterial strains (Staphylococcus aureus, Gram‐positive and Pseudomonas aeruginosa, Gram‐negative bacteria) with the MIC values of 8.91 μM and 17.82 μM respectively. Studies revealed the binding of the complexes with the fundamental phospholipids present in the cell membrane of bacteria, which was found to be the leading cause of bacterial cell death. Cytotoxicity was evaluated using an MTT assay on 293 T cell lines; emphasizing the potential therapeutic uses of the Au(III)‐NHC complexes to control bacterial infections. [ABSTRACT FROM AUTHOR]

Objectives: This research aimed to identify and quantify the antibiofilm activity of bioactive compounds from bacteria isolated from rhizosphere and nodule butterfly pea (Clitoria ternatea), rhizosphere clove afo 3 (Syzygium aromaticum), nodule mimosa (Mimosa pudica L.), and soil from gold mining land which were recovered from Ternate, Tidore, Obi Island, and Marotai Island, Eastern part of Indonesia. Results: Eight supernatants from soil and plant-associated bacteria were found to have quorum quenching activity against Chromobacterium violaceum. All supernatants exhibited antibiofilm activity against biofilm formed by Aeromonas hydrophila and Vibrio harveyi. The supernatant of FT5 showed the highest activity in disrupting (66.59%) and inhibiting (85.63%) the biofilm of A. hydrophila. For V. harveyi, the supernatant of PTM3 showed the highest disruption activity (72.61%), whileRCA7 showed the highest inhibition activity(75.68%). The Gas Chromatography-Mass Spectrometry (GC-MS) identified fatty acids, ester, and diketopiperazine as the compounds related to the antibiofilm activity. Molecular identification revealed that the isolates belong to the genera Bacillus, Priestia, and Chryseobacterium. [ABSTRACT FROM AUTHOR]

Phytochemical composition and antimicrobial, antibiofilm, and antioxidant effects of a newly described Himalayan lichen Placidium deosaiense Usman and Khalid growing in Pakistan were investigated. HPLC–DAD methods were used for identification of secondary metabolites in acetone and methanol extracts. The total phenolics content was measured using a spectrophotometric method. The study investigated the antioxidant (DPPH-scavenging activity assay and reducing-power assay), antibacterial (minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)), and antibiofilm (inhibition of biofilm formation and reduction in mature biofilm) activities of extracts of the lichen P. deosaiense and isolated parietin. The chemical constituents olivetol, olivetolic acid, haematommic acid, fallacinol, and parietin were identified as major compounds in the tested extracts of the lichen. Parietin was isolated from the acetone extract on a separation column. The methanol extract had higher values of TPC (21.67 mg GAE/g) than the acetone extract. Isolated parietin showed the best antioxidant activity measures, according to the DPPH-scavenging activity assay (IC50 = 51.616 μg/mL) and reducing-power assay. Although the extracts showed the best antibacterial activity (especially against Proteus mirabilis ATCC 12453), parietin demonstrated superior antibiofilm activity (especially against Staphylococcus aureus ATCC 25923). This is the first report on the phytochemical composition of the lichen Placidium deosaiense and the first description of the chemical composition of some of the 45 species of the genus Placidium. This research will pave the way for further exploration of new activities of this lichen and its metabolites, which are important for medicine and pharmacy. [ABSTRACT FROM AUTHOR]

The escalating incidence of hospital infections due to antibiotic resistance necessitates the identification of alternative therapeutic agents such as probiotics. This study was designed to isolate and evaluate the efficacy of probiotics against Staphylococcus saprophyticus, a prevalent etiological agent of urinary tract infections (UTIs). A total of 100 S. saprophyticus strains were isolated from clinical samples and subjected to antibiotic susceptibility testing via the disc diffusion method. Concurrently, probiotic bacteria were isolated from Bulgarian cheese and shallot yogurt, and their antibacterial activity against S. saprophyticus strains was assessed. The inhibitory potential of probiotic supernatants was evaluated using microtiter plate assays, with the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) determined at a 1/2 dilution. Cytotoxicity was evaluated using the MTT assay, and high‐performance liquid chromatography (HPLC) was employed to analyze the concentrations of organic acids produced by the probiotics. The results revealed that all S. saprophyticus strains were resistant to tetracycline and doxycycline but susceptible to other antibiotics. Lactobacillus rhamnosus strains M and B demonstrated notable antibacterial and antibiofilm activity against S. saprophyticus isolates. These probiotics exhibited susceptibility to most antibiotics and lacked virulence factors, suggesting their safety for therapeutic use. The organic acids produced by the probiotics were identified as lactic acid, acetic acid, and formic acid. In conclusion, L. rhamnosus strains M and B exhibit potent antimicrobial properties against S. saprophyticus, indicating their potential as therapeutic agents for UTIs. Further research is warranted to validate these findings and explore the possibility of these probiotics in clinical applications. [ABSTRACT FROM AUTHOR]

Staphylococcus aureus is the etiologic agent of many nosocomial infections, and its biofilm is frequently isolated from medical devices. Moreover, the dissemination of multidrug-resistant (MDR) strains from this pathogen, such as methicillin-resistant S. aureus (MRSA) strains, is a worldwide public health issue. The inhibition of biofilm formation can be used as a strategy to weaken bacterial resistance. Taking that into account, we analysed the ability of marine sponge-associated bacteria to produce antibiofilm molecules, and we found that marine Priestia sp., isolated from marine sponge Scopalina sp. collected on the Brazilian coast, secretes proteins that impair biofilm development from S. aureus. Partially purified proteins (PPP) secreted after 24 hours of bacterial growth promoted a 92% biofilm mass reduction and 4.0 µg/dL was the minimum concentration to significantly inhibit biofilm formation. This reduction was visually confirmed by light microscopy and Scanning Electron Microscopy (SEM). Furthermore, biochemical assays showed that the antibiofilm activity of PPP was reduced by ethylenediaminetetraacetic acid (EDTA) and 1,10 phenanthroline (PHEN), while it was stimulated by zinc ions, suggesting an active metallopeptidase in PPP. This result agrees with mass spectrometry (MS) identification, which indicated the presence of a metallopeptidase from the M28 family. Additionally, whole-genome sequencing analysis of Priestia sp. shows that gene ywad, a metallopeptidase-encoding gene, was present. Therefore, the results presented herein indicate that PPP secreted by the marine Priestia sp. can be explored as a potential antibiofilm agent and help to treat chronic infections. [ABSTRACT FROM AUTHOR]

Background: Foodborne disease and food spoilage are the prime public health issue and food security round the globe. Significant disease outbreaks mostly linked to the existence of pathogenic bacteria that extremely challenging due to the persistence of biofilm-forming. Proteins and bacterial metabolites have been shown to have good antibacterial activity and effectively removal bacterial biofilm. Recently, bacteriophage and their encoded lytic proteins such as lysin have attracted attention as potential alternative agent to control undesirable pathogens in human body infection, increasing food safety as advance preservations and medical treatment such as phage therapy. For these reasons, the efficacy of bacteriophage and their potential in combination with bacterial metabolites from Phyllosphere and Actinomycetes bacteria (Pseudomonas fluorescens JB3B and Streptomyces thermocarboxydus 18PM crude extracts) was the aim of this present study. Results: In this study, bacteriophage BC-VP (1.28 ± 0.29 × 1011 PFU/ml) and ETEC-phage-TG (8.9 ± 2.19 × 108 PFU/ml) isolated from artificial lake water from previous study showed potential activity to control Bacillus cereus (BC) and Enterotoxigenic Escherichia coli (ETEC) population. The combination of BC-VP with metabolite (P. fluorescens JB3B and S. thermocarboxydus 18PM) which were known from previous study had antibiofilm activities were able to inhibit (86.1%; 83.3%) and destruct (41%; 45.5%) biofilm formation of B. cereus respectively. Likewise, the synergy of bacteriophage ETEC-phage-TG with the same crude extract also showed promising activity against biofilm of ETEC with percentage of inhibition (81.9%; 76.4%) and percentage of destruction (54.1%; 44.4%). Application in various food, combination of BC-VP and bacterial metabolite extract (P. fluorescens JB3B; S. thermocarboxydus 18PM) were able to reduce Bacillus cereus population in mashed potato (99.6%; 99.4%) at cold temperature (4 °C) and (68.9%; 56.6%) at room temperature (28 °C), boiled pasta (99.5%; 99.4%) and (84.7%; 75.7%), also soymilk (96.9%; 96.7%) and (42.4%; 39.4%) respectively. Likewise, combination of ETEC-phage-TG and bacterial metabolite (P. fluorescens JB3B; S. thermocarboxydus 18PM) potentially reduced ETEC population after two different temperatures (4 °C and 28 °C) incubation in bean sprouts (TFTC; TFTC) and (47.5%; 49.1%), chicken meat (TFTC; TFTC) and (58.1%; 54%), also minced beef (99.5%; 99.4%) and (41.1%; 28%). GC-MS determination performed, oxalic acid, phenol, phenylethyl alcohol, N-hexadecanoic acid, and pyrolol[1,2-a]pyrazine-1,4-dione, hexadro-3-92-methylpropyl was the most active compound in P. fluorescens JB3B. 2,4-Di-tert-butylphenol, phenyl acetic acid, N-Hexadecanoic acid, pyrolol[1,2-a]pyrazine-1,4-dione, hexadro-3-92-methylpropyl, and Bis(2-ethylhexyl) phthalate was most active compound in the S. thermocarboxydus 18PM isolates. Conclusions: The combination of isolated bacteriophages and bacterial metabolite showed promising results to be used as biocontrol candidate to overcome biofilm formed by foodborne and food spoilage bacteria using their ability to produce antibiofilm compounds and lytic activity. In addition, this combination also potentially reduces the use or replace the drawbacks of common application such as antibiotic treatment. [ABSTRACT FROM AUTHOR]

Food waste is an excellent source of various bioactive secondary metabolites. In addition, food waste is a global issue, and more research is being focused on the conversion of value-adding products from food waste, especially fruits. In this study, bioactive polyphenols were extracted from orange peels. The parameters that affect the extraction of polyphenols from orange peels were optimized using response surface methodology. Ethanol was used to extract bioactive polyphenols, and the extraction time (min), extraction temperature, and ethanol concentration (%) were analyzed. Orange peels are an excellent source of polyphenols, and the yield was increased under optimized extraction conditions (p<0.05). The polyphenol content increased twofold (38.4 mg GAE/g) under the optimized extraction conditions (53% ethanol, 51 degrees centigrade and 96 min extraction time). Crude polyphenols exhibited significant antibacterial activity against Bacillus subtilis (19±1 mm zone of inhibition), followed by Staphylococcus aureus (17±2 mm zone of inhibition) (p<0.05). In addition, orange peel extract exhibited antifungal activity against A. flavus and C. albicans. The ethanol extract exhibited DPPH activity (1.61±0.03 mg GAE/100 g) and ABTS reducing power (1.48±0.01 mg GAE/100 g). The polyphenol compounds exhibited antibiofilm activity against biofilm-producing Bacillus subtilis and increased in a dose-dependent manner (p<0.05). [ABSTRACT FROM AUTHOR]

Black bean skin anthocyanins (BBSAs), as by‐products of black beans, have not been fully exploited. BBSAs are rich in anthocyanins and have a wide range of health benefits. In this study, the antibacterial and antibiofilm action mode of BBSAs against Vibrio parahaemolyticus (V. parahaemolyticus) was evaluated. The antibacterial and antibiofilm efficiency was evaluated under different conditions, shedding light on their mode of action against V. parahaemolyticus. The results showed that the inactivation efficacy of BBSAs on V. parahaemolyticus was positively correlated with its concentration and incubating time. The MIC value for BBSAs was determined to be 10 μg/mL. The formation of V. parahaemolyticus biofilm was hindered by the presence of the BBSAs, especially at higher concentrations of BBSAs and during the early intervention stage. After exposure to 1 MIC of BBSA, the inhibition rate of biofilm reached 91.94%. The release of cellular components and alterations in membrane morphology indicated that BBSAs can damage the integrity of V. parahaemolyticus cell membrane. Furthermore, BBSAs may interact with membrane proteins, causing a notable conformational change in membrane proteins. HPLC and UPLC‐MS analysis confirmed that the major antibacterial compound in BBSAs was Cyanidin‐3‐O‐glucoside (C3G), which can form a stable complex with LolB protein in the outer membrane via hydrogen bonding. This study can provide strong technical support for the accurate control of V. parahaemolyticus and pave the way for the application of natural antibacterial agents in the realm of food‐borne bacterial control. [ABSTRACT FROM AUTHOR]

One of the major global health threats in the present era is antibiotic resistance. Biosynthesized iron oxide nanoparticles (FeNPs) can combat microbial infections and can be synthesized without harmful chemicals. In the present investigation, 16S rRNA gene sequencing was used to discover Streptomyces sp. SMGL39, an actinomycete isolate utilized to reduce ferrous sulfate heptahydrate (FeSO4.7H2O) to biosynthesize FeNPs, which were then characterized using UV–Vis, XRD, FTIR, and TEM analyses. Furthermore, in our current study, the biosynthesized FeNPs were tested for antimicrobial and antibiofilm characteristics against different Gram-negative, Gram-positive, and fungal strains. Additionally, our work examines the biosynthesized FeNPs' molecular docking and binding affinity to key enzymes, which contributed to bacterial infection cooperation via quorum sensing (QS) processes. A bright yellow to dark brown color shift indicated the production of FeNPs, which have polydispersed forms with particle sizes ranging from 80 to 180 nm and UV absorbance ranging from 220 to 280 nm. Biosynthesized FeNPs from actinobacteria significantly reduced the microbial growth of Fusarium oxysporum and L. monocytogenes, while they showed weak antimicrobial activity against P. aeruginosa and no activity against E. coli, MRSA, or Aspergillus niger. On the other hand, biosynthesized FeNPs showed strong antibiofilm activity against P. aeruginosa while showing mild and weak activity against B. subtilis and E. coli, respectively. The collaboration of biosynthesized FeNPs and key enzymes for bacterial infection exhibits hydrophobic and/or hydrogen bonding, according to this research. These results show that actinobacteria-biosynthesized FeNPs prevent biofilm development in bacteria. [ABSTRACT FROM AUTHOR]

Microbial biofilm formation on medical devices paves the way for device-associated infections. Staphylococcus epidermidis is one of the most common strains involved in such infections as it is able to colonize numerous devices, such as intravenous catheters, prosthetic joints, and heart valves. We previously reported the antibiofilm activity against S. epidermidis of pentadecanoic acid (PDA) deposited by drop-casting on the silicon-based polymer poly(dimethyl)siloxane (PDMS). This material exerted an antibiofilm activity by releasing PDA; however, a toxic effect on bacterial cells was observed, which could potentially favor the emergence of resistant strains. To develop a PDA-functionalized material for medical use and overcome the problem of toxicity, we produced PDA-doped PDMS by either spray-coating or PDA incorporation during PDMS polymerization. Furthermore, we created a strategy to assess the kinetics of PDA release using ADIFAB, a very sensitive free fatty acids fluorescent probe. Spray-coating resulted in the most promising strategy as the concentration of released PDA was in the range 0.8–1.5 μM over 21 days, ensuring long-term effectiveness of the antibiofilm molecule. Moreover, the new coated material resulted biocompatible when tested on immortalized human keratinocytes. Our results indicate that PDA spray-coated PDMS is a promising material for the production of medical devices endowed with antibiofilm activity. [ABSTRACT FROM AUTHOR]

Biofilms are complex bacterial colonies embedded in an extracellular matrix. These pose a major obstacle to wound healing and are noticeable in chronic wounds. It protects the bacteria from the host's immune system and conventional antibiotic treatments. The biofilm's protective matrix prevents essential nutrients and oxygen from diffusing into the surrounding healthy tissue. In addition, microbes living in biofilms naturally have increased resistance to antibiotics, which reduces the effectiveness of traditional therapies. As such, biofilms serve as persistent reservoirs of infection, which further disrupts the normal course of wound healing. In this review, the current formulation strategies such as hydrogels, polymeric nanoparticles, and nanofibers that are used in wound healing to counteract biofilms have been comprehensively discussed. The formulations have been meticulously designed and developed to disturb the biofilm matrix, prevent the growth of microorganisms, and increase the potency of antimicrobials and antibiotics. The mechanism of action, advantages and limitations associated with the existing formulation strategies have been reviewed. The formulation strategies that have been translated into clinical applications and patented are also discussed in this paper. [ABSTRACT FROM AUTHOR]

The continuous growth of biofilm infections and their resilience to conventional cleaning methods and antimicrobial agents pose a worldwide challenge across diverse sectors. This persistent medical, industrial, and environmental issue contributes to treatment challenges and chronic diseases. Lactic acid bacteria have garnered global attention for their substantial antimicrobial effects against pathogens and established beneficial roles. Notably, their biofilms are also predicted to show a promising control strategy against pathogenic biofilm formation. The prevalence of biofilm-related problems underscores the need for extensive research and innovative solutions to tackle this global challenge. This novel study investigates the effect of different extracts (external, internal, and mixed extracts) obtained from Lactobacillus rhamnosus GG biofilm on pathogenic-formed biofilms. Subsequently, external extracts presented an important eradication effectiveness. Furthermore, a 6-fold concentration of these extracts led to eradication percentages of 57%, 67%, and 76% for Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa biofilms, respectively, and around 99.9% bactericidal effect of biofilm cells was observed for the three strains. The results of this research could mark a significant breakthrough in the field of anti-biofilm and antimicrobial strategies. Further studies and molecular research will be necessary to detect the molecules secreted by the biofilm, and their mechanisms of action engaged in new anti-biofilm strategies. Key points: • Using L. rhamnosus GG biofilm extracts to eradicate pathogenic biofilms. Antimicrobial effect of L. rhamnosus GG biofilm external extracts against biofilm-associated bacteria. Increasing biofilm eradication by combining with a mixture of antimicrobial agents. [ABSTRACT FROM AUTHOR]

The rise of vancomycin-resistant enterococci (VRE) due to antibiotic overuse poses a significant threat to long-term care patients and those with impaired immune systems. Therefore, it is imperative to seek alternatives to overcome multidrug resistance. This study aimed to evaluate totarol, a natural compound derived from Podocarpus totara, for its antibacterial activity against vancomycin-resistant Enterococcus faecalis (VREF). Totarol exhibited potent antibacterial activity at a very low concentration of 0.25 µg/mL and demonstrated antibiofilm effects through biofilm inhibitory concentration and biofilm eradication concentration assays. Confocal laser scanning microscopy confirmed that totarol inhibited not only biofilm mass but also bacterial cell viability. The combinatorial use of sublethal concentrations of totarol and vancomycin showed antibacterial activity, as observed in the time-kill assay. Quantitative polymerase chain reaction assays revealed a concentration-dependent downregulation of key virulence genes (vanA, ace, asa, efaA, and esp) in VREF when exposed to totarol. In summary, totarol emerges as a promising adjuvant with vancomycin for inhibiting VREF, addressing vancomycin resistance and biofilm formation—critical challenges associated with VRE infection. Since this was an in vitro study, the role of totarol in the clinical implications of VREF treatment remains to be demonstrated. [ABSTRACT FROM AUTHOR]

Background: Indonesia is a country that uses half or more aquatic foods as protein intake. The increased production in aquaculture industries might cause several problems, such as bacterial disease resulting in mass mortality and economic losses. Antibiotics are no longer effective because aquaculture pathogens can form biofilm. Biofilm is a microbial community that aggregates and firmly attaches to living or non-living surfaces. Biofilm formation can be caused by environmental stress, the presence of antibiotics, and limited nutrients. Therefore, it is important to explore antibiofilm to inhibit biofilm formation and/or eradicate mature biofilm. Phyllosphere bacteria can produce bioactive compounds for antimicrobial, antibiofilm, and anti-quorum sensing. Three aquaculture pathogens were used in this study, such as Aeromonas hydrophila, Streptococcus agalactiae, and Vibrio harveyi. Results: Pseudomonas fluorescens JB3B and Morganella morganii JB8F extracts could disrupt single and multi-species biofilms. Both extracts could inhibit single biofilm formation from one to seven days of incubation time. We confirmed the destruction activity on multi-species biofilm using light microscope and scanning electron microscope. Using GC-MS analysis, indole was the most active fraction of the P. fluorescens JB3B extracts and octacosane from the M. morganii JB8F extract. We also conducted a toxicity test using brine shrimp lethality assay on P. fluorescens JB3B and M. morganii JB8F extracts. P. fluorescens JB3B, M. morganii JB8F, and a mixture of both extracts were confirmed non-toxic according to the LC50 value of the brine shrimp lethality test. Conclusions: P. fluorescens JB3B and M. morganii JB8F phyllosphere extracts had antibiofilm activity to inhibit single biofilm and disrupt single and multi-species biofilm of aquaculture pathogens. Both extracts could inhibit single species biofilm until seven days of incubation. Bioactive compounds that might contribute to antibiofilm properties were found in both extracts, such as indole and phenol. P. fluorescens JB3B, M. morganii JB8F extracts, and mixture of both extracts were non-toxic against Artemia salina. [ABSTRACT FROM AUTHOR]

Foodborne pathogens may cause foodborne illness, which is among the major health problems worldwide. Since the therapeutic options for the treatment of the disease are becoming limited as a result of antibacterial resistance, there is an increasing interest to search for new alternatives of antibacterial. Bioactive essential oils from Curcuma sp become potential sources of novel antibacterial substances. The antibacterial activity of Curcuma heyneana essential oil (CHEO) was evaluated against Escherichia coli, Salmonella typhi, Shigella sonnei, and Bacillus cereus. The principal constituents of CHEO are ar-turmerone, β-turmerone, α-zingiberene, α-terpinolene, 1,8-cineole, and camphor. CHEO exhibited the strongest antibacterial activity against E. coli with a MIC of 3.9 µg/mL, which is comparable to that of tetracycline. The combination of CHEO (0.97 µg/mL) and tetracycline (0.48 µg/mL) produced a synergistic effect with a FICI of 0.37. Time-kill assay confirmed that CHEO enhanced the activity of tetracycline. The mixture disrupted membrane permeability of E. coli and induced cell death. CHEO at MIC of 3.9 and 6.8 µg/mL significantly reduced the formation of biofilm in E. coli. The findings suggest that CHEO has the potential to be an alternative source of antibacterial agents against foodborne pathogens, particularly E. coli. [ABSTRACT FROM AUTHOR]

Antibiotic resistance is a significant global health problem primarily caused by the inappropriate use of antibiotics. Therefore, the inadequacy of antibiotics in treating infections has led to exploring effective alternative treatment options, such as natural sources like essential oils. Mentha longifolia subsp. typhoides (Lamiaceae) is an economically important medicinal and aromatic plant used in traditional medicine as a spice and herbal tea. This study aimed to characterize the essential oil composition of this species (MLT-EO) and its biological activities. The chemical composition of the MLT-EO was analyzed using gas chromatography (GC) and GC-mass spectrometry (GC–MS). Piperitenone (25.7%), carvone (22.7%), piperitone (22.8%), pulegone (6.8%), and isomenthone (6.6%) were characterized as the main components. The MLT-EO exhibits antibacterial activity against Gram-negative bacteria. The MLT-EO exhibited the best MIC value against the test fungi, with <0.625 mg/mL values against Candida parapsilosis strains. The percentage of biofilm inhibition value of the MLT-EO (10 mg/mL) was 59.53%, and the percentage of violacein inhibition values calculated for sub-MICs concentrations of the MLT-EO (1 mg/mL and 0.5 mg/mL) were 63.68% and 38.08%, respectively. The results show that the high level of piperitenone, carvone, and piperitone detected in the MLT-EO may be responsible for these effects. [ABSTRACT FROM AUTHOR]

Microbial infections are the most significant threats to human health, and there has been a recent increase in the number of deaths exclusively attributed to bacterial and fungal infections. The development of biofilms by bacterial and fungal pathogens has been identified as a key adaptive antimicrobial resistance (AMR) mechanism, in addition to intrinsic and extrinsic AMR. Various bioactive molecules have been isolated from marine organisms for use in biofilm therapies. These compounds are structurally complex, biocompatible, and economically viable. Studies have demonstrated that bioactive chemicals obtained from marine sources, marine-bioinspired nanomaterials, and marine polymer-antibiotic conjugates can control the biofilms and virulence factors of microbial pathogens. Microbial infections are major human health issues, and, recently, the mortality rate owing to bacterial and fungal infections has been increasing. In addition to intrinsic and extrinsic antimicrobial resistance mechanisms, biofilm formation is a key adaptive resistance mechanism. Several bioactive compounds from marine organisms have been identified for use in biofilm therapy owing to their structural complexity, biocompatibility, and economic viability. In this review, we discuss recent trends in the application of marine natural compounds, marine-bioinspired nanomaterials, and marine polymer conjugates as possible therapeutic agents for controlling biofilms and virulence factors. We also comprehensively discuss the mechanisms underlying biofilm formation and inhibition of virulence factors by marine-derived materials and propose possible applications of novel and effective antibiofilm and antivirulence agents. [ABSTRACT FROM AUTHOR]

Non-steroidal anti-inflammatory drugs (NSAIDs) have received attention to be used in combination with antibiotics in antibacterial chemotherapy. However, this study is the first to explore the impact of dual encapsulation of diclofenac sodium and gentamicin within PLGA nanoparticles (DS-GEN-PLGA NPs) on inhibiting extracellular matrix components and biofilm eradication of Pseudomonas aeruginosa PAO1. DS-GEN-PLGA NPs were prepared using the double emulsion solvent evaporation (DESE) technique and characterized by various characterization techniques. Subsequently, the inhibition and eradication potential of DS-GEN-PLGA NPs against P. aeruginosa biofilm was explored. The DS-GEN-PLGA NPs are spherical and oval and 80–200 nm in diameter. DS-GEN-PLGA NPs significantly reduced biofilm formation by 76.28%, biofilm metabolic level by 69.8%, biofilm exopolysaccharide by 75.3%, alginate production by 32.56%, and eDNA release by 60.2%. The expression level of the lasI and rhlI decreased by 0.29 and 0.44 folds compared with untreated cells. This study indicates that DS-GEN-PLGA NPs have promising antibiofilm activity against P. aeruginosa, highlighting its potential as a novel therapeutic formulation to combat biofilm-related infections. [ABSTRACT FROM AUTHOR]

Hydroxyapatite (HA) forms an essential constituent of human teeth and bone. Its distinctive characteristic features, such as bioactivity and osteoconductivity, make it an ideal candidate to be used as an implant coating in restorative dentistry and maxillofacial surgery for bone regeneration. However, low fracture toughness and brittleness are a few of the inherent features of HA, which limit its application in load-bearing areas. The potential of HA to engage its lattice structure with either partial or complete substitution with external ions has become an increasing area of research as this phenomenon has the potential to enhance the biological and functional properties of the material. Consequently, this review aimed to highlight the role of various substituted ions in dental applications. Data indicate that the newly formed HA-substituted biomaterials demonstrate enhanced remineralization and antimicrobial activity along with improved hardness. Ion-substituted HA offers a promising strategy for future clinical research as these materials may be incorporated into various dental products for therapeutic treatments. [ABSTRACT FROM AUTHOR]

Bacteria such as Staphylococcus aureus and Escherichia coli are the most common causes of foodborne illness. Candida tropicalis is also found in the faeces of chronic diarrhoea patients. Biofilms can form on the surfaces of living or inanimate objects. Biofilm formation contributes to various infections and makes their eradication difficult. The Nephelium mutabile plant is known to have active substances that are antibacterial, anti-oxidative, anti-inflammatory, anti-mutagenic, and anti-carcinogenic. The objective of this study is to determine the effectiveness of Nephelium mutabile leaf extract in inhibiting biofilms formed by Staphylococcus aureus, Escherichia coli, and Candida tropicalis. This study used a Completely Randomized Design [CRD] with two sample groups: the sample group with the addition of Nephelium mutabile extract before biofilm formation and the group sample without any treatment. The concentration of Nephelium mutabileleaf extract for the biofilm inhibition test was 25%. Distilled water is used for negative control. Nephelium mutabile extract was most effective in inhibiting the formation of a Candida tropicalis biofilm [92.24%], and the lowest effectiveness inhibited the formation of Staphylococcus aureus biofilm [35.76%]. Nephelium mutabile leaf extract has the potential to be an antibiofilm for bacteria and fungi [Staphylococcus aureus, Escherichia coli, and Candida tropicalis]. [ABSTRACT FROM AUTHOR]